Assistant Professor of Medicine, Associate Clinical Director, MGH Lipid and Metabolism Associates
Massachusetts General Hospital and Harvard Medical School
Disclosure(s): Chiesi Farmaceutici: Advisor/Consultant, Grant/Research Support; Theratechnologies: Advisor/Consultant
Dr. Fourman is an endocrinologist and Assistant Professor of Medicine at Massachusetts General Hospital and Harvard Medical School. She has a robust clinical research program geared toward elucidating mechanisms and treatment strategies for cardiometabolic disease. Her research portfolio includes studies focused on use of tesamorelin to treat nonalcoholic fatty liver disease among people with HIV as well as the investigation of long-term health outcomes among individuals with perinatal HIV exposure. Clinically, Dr. Fourman is Associate Director of MGH Lipid and Metabolism Associates, which serves as a center of excellence for the management of patients with HIV-related cardiometabolic disorders such as abdominal fat accumulation. She also directs the MGH Metabolic Disorders Conference, which melds clinical experience with scientific literature to develop best practices for various lipid and metabolic diseases.
Disclosure(s):
Dr. Fourman serves as a consultant for Theratechnologies. She also serves as a consultant and receives grant funding to her institution from Amryt Pharmaceuticals, unrelated to this work.